THC

EQS-News: Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market

Retrieved on: 
Wednesday, April 10, 2024
Pillar, Betäubungsmittelgesetz, Federal Council, Organization, Growth, Partnership, Cannabis Act, Statista, Cannabis, Criminal law, Applied science, Weßling, THC, Advertising, Vocational university, Drug

Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market

Key Points: 
  • Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market
    The issuer is solely responsible for the content of this announcement.
  • Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market
    Cannovum Cannabis AG (stock exchanges Frankfurt/Xetra, Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A37FUP2) welcomes the legalization of cannabis in Germany confirmed today by the Federal Council.
  • This will provide new impetus for a billion-euro market in Europe's largest economy in the coming years.
  • Cannovum Cannabis AG plans to generate significant sales through offers for existing and emerging cannabis clubs.

Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology

Retrieved on: 
Tuesday, April 9, 2024
CBG, LCM, MCT, Health, USDA, Cannabinoid, Absorption, Oil, CBGA, Biotechnology, Textile, Relaxation, Paint, Risk, Coffee, Clothing, GMO, Cellulose, News, Anxiety, University, Food, Cannabis, Plant, CBDA, CBN, OTC, Restaurant, Water, Jan Vansina, THC, Paper, Agriculture

The newly approved GMO hemp variety, a breakthrough by the University of Wisconsin, is known as "Badger G".

Key Points: 
  • The newly approved GMO hemp variety, a breakthrough by the University of Wisconsin, is known as "Badger G".
  • Hemp, Inc. recognizes the pivotal role of biotechnology in the evolution of the cannabis industry.
  • This innovative strain stands to solve a pivotal problem in the hemp cultivation sector: regulatory compliance regarding THC levels.
  • This milestone in GMO hemp sets the stage for Hemp, Inc. to continue its commitment to innovation, sustainability, and legal compliance within the industry.

Grön Announces Launch of 300mg Sugar-Coated Pearl Packs in Missouri

Retrieved on: 
Tuesday, April 9, 2024
THC, Watermelon, Tea

PORTLAND, Ore., April 09, 2024 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the acclaimed woman-led producer of delicious, handcrafted cannabis-infused edibles, today announced the launch of 30 milligram Sugar-Coated Pearls in Missouri. Made with real fruit and infused with cannabis extract, Grön’s new higher-dose Sugar-Coated Pearls have 30mg THC per Pearl, delivering a total of 300mg THC per box. With flavors meticulously curated to perfection, consumers can savor a symphony of taste sensations, including Raspberry Lemonade and Watermelon.

Key Points: 
  • PORTLAND, Ore., April 09, 2024 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the acclaimed woman-led producer of delicious, handcrafted cannabis-infused edibles, today announced the launch of 30 milligram Sugar-Coated Pearls in Missouri.
  • Made with real fruit and infused with cannabis extract, Grön’s new higher-dose Sugar-Coated Pearls have 30mg THC per Pearl, delivering a total of 300mg THC per box.
  • With flavors meticulously curated to perfection, consumers can savor a symphony of taste sensations, including Raspberry Lemonade and Watermelon.
  • Beloved by Grön enthusiasts, the original 10mg Sugar-Coated Pearls have long been a hallmark of the brand's delightful product line.

Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup

Retrieved on: 
Thursday, April 4, 2024
Melon, Cream, CBG, Culture, Burn, Limonene, Hibiscus, Gasoline, TLRY, Snow, Partnership, Lotus, CBD, GOOD, TSX, Love, Cranberry, Cheese, Fruit, Ammonia, Candy, THC, Citrus, Drug

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.

Key Points: 
  • TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.
  • Cannabis enthusiasts and cannabis-curious consumers alike are invited to learn about Tilray Brands’ products at local cannabis retailers.
  • In celebration of 420 and the ever-changing landscape of cannabis innovation and culture, Tilray Brands invites consumers to explore a new range of diverse cannabis products from its leading brands.
  • Broken Coast EmergenZ and Cherry Cheesecake: Broken Coast presents two exceptional strains for 420 with unique aromas and taste profiles.

RC Show 2024 Releases Sneak Peek at its Dynamic Speaker Lineup

Retrieved on: 
Wednesday, April 3, 2024
The French Laundry, History, Workshop, Wine, ICAN, Restaurant, THC, Accident, DEI, Interac, Inclusion, Certification, LEVEL, Diversity, Coffee, Cannabis, Interim, Breakfast, Organization, MasterClass, Woman, Philosophy, Food, BDC, Introduction, RC, Happy Accidents, Guinness, Family, Food safety, Wagman, Netflix, Ipsos, Blueprint, CBD, Life, Collection, Management

Learn about the latest innovations, valuable insights, current issues, and discover solutions that will help support the industry going forward.

Key Points: 
  • Learn about the latest innovations, valuable insights, current issues, and discover solutions that will help support the industry going forward.
  • RC Show gives attendees access to world-class educational and interactive speaker sessions, workshops and panels over three days, across six stages.
  • Here’s a taste of this year’s programming highlights and who RC Show is bringing to the table:
    Kick off the RC Show Speaker Series with a bang.
  • Catch her bartending skills live and up-close on the RC Pop-Up Stage April 9, 11 a.m.-1 p.m.

Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use

Retrieved on: 
Wednesday, April 3, 2024
Epilepsy, CCPS, Health, TLRY, HIV, Arthritis, Post-traumatic stress disorder, Patient, Tilray, Anxiety, Tobacco, Chronic pain, CBD, Essential tremor, Cannabis, TSX, Signs and symptoms, Pain, THC, Vomiting, Pharmaceutical industry

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, today announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada. The new study was derived from the Canadian Cannabis Patient Survey (CCPS) 2021, comprised of 2,697 patients and focused primarily on older patients with a mean age of 54.3. This study presents to the medical and scientific community the consumption trends observed in patients and the self-reported impacts from medical cannabis in alleviating the patients’ primary symptoms.

Key Points: 
  • Tilray Led Study Shows Chronic Pain, Arthritis, Anxiety, and Insomnia as Primary Illnesses and Symptoms for Medical Cannabis Use
    NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, today announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada .
  • This study presents to the medical and scientific community the consumption trends observed in patients and the self-reported impacts from medical cannabis in alleviating the patients’ primary symptoms.
  • The Age-related Patterns of Medical Cannabis Use study finds that older patients comprise a growing subset of medical cannabis patients.
  • José Tempero, Tilray’s Medical Director, said, "Our role in this initiative exemplifies our commitment to medical research, leading us one step closer to unlocking the full therapeutic potential of medical cannabis."

Klik Empowers Creative Expression and Economic Opportunity

Retrieved on: 
Tuesday, April 2, 2024
Conference, Child, Entrepreneurship, NFT, Non-fungible token, Cannabis, Heart, Creativity, Safety, Music, THC

David Zelinger, Co-Founder of Klik, expressed his enthusiasm, stating, "We are at the cusp of a new era in content creation and distribution.

Key Points: 
  • David Zelinger, Co-Founder of Klik, expressed his enthusiasm, stating, "We are at the cusp of a new era in content creation and distribution.
  • The event is a testament to the economic opportunities presented by blockchain-based engagements, offering a new paradigm of value creation and distribution.
  • 'The Rugged Child' event is a perfect example of how technology and creativity converge to create new avenues for expression and entrepreneurship."
  • This collaboration between The Blinc Group and Klik underscores the shared vision of leveraging technology to enhance creative expression and economic opportunity within the cannabis community and beyond.

Ike’s is Rollin' Up the Ultimate Munchie Fix: The THC Sandwich

Retrieved on: 
Tuesday, April 2, 2024
Friends, Taste, Appetite, Sandwich, Cheetos, News, Weedmaps, Love, Cheese, THC, Fast food

They're teaming up with Weedmaps – yeah, that place where you find all the best green goodies – to drop something epic: the THC Sandwich.

Key Points: 
  • They're teaming up with Weedmaps – yeah, that place where you find all the best green goodies – to drop something epic: the THC Sandwich.
  • The sandwich doesn’t have any actual THC but it's a full sesh with every bite.
  • And here’s a pro tip: Ike’s Rewards members score $4.20 off their THC Sandwich on April 20.
  • For the down-low on the THC Sandwich and all the latest Ike’s news, hit us up online or slide into the DMs at @ikesandwiches .

Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors

Retrieved on: 
Tuesday, April 2, 2024
MIS, Brunel University London, Management information system, University of Detroit Mercy, Research, United Nations, University, IBM, Health, Morgan Stanley, Doctor of Philosophy, BT Group, Publication, Roche, World Health Organization, OTC, Telecom, Book, THC, Blood, Consultant, Medical device

VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that Dr. Phillip Olla (Ph.D.) has joined the board of directors.

Key Points: 
  • VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that Dr. Phillip Olla (Ph.D.) has joined the board of directors.
  • Dr. Olla is an expert in breath technologies, breathomics, healthcare innovation, artificial and medical informatics.
  • Dr. Olla is one of only a handful of scientists globally who has ever conducted delta-9 THC analysis in blood and breath.
  • Dr. Olla is an associate professor at University of Detroit Mercy in Michigan and is the Vice Chair of the MedHealth Consortium.

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, April 1, 2024
Financial statement, Certification, HBI, Consolidated, Partnership, Accounting Standards Codification, Patient, Sale, RDC, Sales, Closing, GMP, Procurement, ASC, Traction, Interest, ATM, Security, Note, Investment, THC, Pharmaceutical industry

TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information is provided in US dollars unless otherwise indicated.

Key Points: 
  • Subsequent to the end of the fourth quarter, we completed the $1.5 million sale of our Portuguese farm assets.
  • As we progress into 2024, we remain focused on driving further capital preservation and operational efficiencies.”
    Fourth Quarter 2023 Summary vs.
  • Same Year-Ago Quarter1
    Revenue in the fourth quarter of 2023 increased 5% to $4.6 million compared to $4.4 million for the same period in 2022.
  • Net loss in 2023 includes a $3.7 million loss on investment related to the fourth quarter sale of the Company’s remaining Cansativa stake.